Trademark: 88570483
Word
X PARSOLEX PARTNER SOLUTIONS EXCELLENCE
Status
Registered
Status Code
700
Status Date
Tuesday, May 18, 2021
Serial Number
88570483
Registration Number
6356727
Registration Date
Tuesday, May 18, 2021
Mark Type
3000
Filing Date
Wednesday, August 7, 2019
Published for Opposition
Tuesday, July 28, 2020

Trademark Owner History
Parsolex GMP Center, Inc. - Original Registrant

Classifications
42 Consulting services in the fields of pharmaceutical, medical and healthcare research and development; technical services, namely, research and development in the pharmaceutical and biotechnology fields; consulting services for pharmaceutical formulation design, design of processes to transform inorganic and organic substances and pharmaceutical technology transfer being advice and information about pharmaceutical research and design; technical services, namely, providing advice, information and instructions for pharmaceutical formulation design and design of processes to transform inorganic and organic substances, pharmaceutical technology transfer being advice and information about pharmaceutical research and design; pharmaceutical product chemical and physical evaluation services, namely, test method development, test method validation, use of test methods for in-process control, quality control, and product release, and technology transfer being advice and information about pharmaceutical test methods; analytical chemistry services, namely, developing and validating test methods for drug product release; technology transfer being advice and information about the drug product testing process and test methods; providing services to others in the fields of analytical, chemistry and manufacturing controls for the production and regulatory approval of pharmaceuticals, namely, providing scientific information relating to the analysis and management of the pharmaceutical manufacturing process for the production, packaging, and regulatory approval of pharmaceuticals; consulting services in the fields of chemistry, biotechnology, pharmaceutical research and development, laboratory testing, and diagnostics; consulting and research and development services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; technical consulting in the fields of pharmaceutical studies, research and development; technical consulting in the field of pharmaceutical development and engineering; technical consulting in the field of analytical chemistry services; consultancy pertaining to pharmacology; technology consultation in the fields of research and development of pharmaceuticals, medicines and healthcare products; scientific research consulting in the fields of pharmaceuticals, medicines and healthcare products; product development consulting in the fields of pharmaceuticals, medicines and healthcare products; scientific research services relating to pharmaceuticals, medicines and healthcare products; product development consultation; product development services; formulation and process design services for drug products for others; outsource service provider for manufacturing and packaging of pharmaceuticals; formulation and process design services for drug products for others; design of packaging for pharmaceuticals of others; pharmaceutical product packaging design services for others; formulation and process design services for drug products of others; provision of information, advice and consultancy in relation to pharmaceutical packaging design; technical consulting in the field of pharmaceutical research and development; custom pharmaceutical service provider, namely, pharmaceutical formulation design, design of processes to transform inorganic and organic substances, and chemical and physical evaluation of pharmaceuticals; consulting in the areas of pharmaceutical formulation design, design of processes to transform inorganic and organic substances, and chemical and physical evaluation of pharmaceuticals; development of custom pharmaceuticals for others; design of packaging for pharmaceuticals for others; formulation and process design services for drug products for others
The mark consists of a stylized design comprised of two diagonal intersecting pill capsules forming a heart shaped arrow design on the left side and creating an "x" shape; the design element appears to the left of the wording "Parsolex"; centered underneath the design and "Parsolex" wording appears the wording "PARTNER SOLUTIONS EXCELLENCE".
Color is not claimed as a feature of the mark.
"SOLUTIONS"

Trademark Events
May 18, 2021
Registered-Principal Register
Apr 16, 2021
Notice Of Acceptance Of Statement Of Use E-Mailed
Apr 15, 2021
Allowed Principal Register - Sou Accepted
Apr 2, 2021
Statement Of Use Processing Complete
Mar 17, 2021
Use Amendment Filed
Apr 1, 2021
Case Assigned To Intent To Use Paralegal
Mar 17, 2021
Teas Statement Of Use Received
Sep 22, 2020
Noa E-Mailed - Sou Required From Applicant
Jul 28, 2020
Official Gazette Publication Confirmation E-Mailed
Jul 28, 2020
Published For Opposition
Jul 8, 2020
Notification Of Notice Of Publication E-Mailed
Jun 24, 2020
Law Office Publication Review Completed
Jun 16, 2020
Approved For Pub - Principal Register
Jun 16, 2020
Examiner's Amendment Entered
Jun 16, 2020
Notification Of Examiners Amendment E-Mailed
Jun 16, 2020
Examiners Amendment E-Mailed
Jun 16, 2020
Examiners Amendment -Written
Jun 16, 2020
Previous Allowance Count Withdrawn
Jun 15, 2020
Withdrawn From Issue - Managing Attorney Request
May 26, 2020
Official Gazette Publication Confirmation E-Mailed
May 26, 2020
Published For Opposition
May 6, 2020
Notification Of Notice Of Publication E-Mailed
Apr 22, 2020
Approved For Pub - Principal Register
Apr 22, 2020
Examiner's Amendment Entered
Apr 22, 2020
Notification Of Examiners Amendment E-Mailed
Apr 22, 2020
Examiners Amendment E-Mailed
Apr 22, 2020
Examiners Amendment -Written
Apr 16, 2020
Teas/Email Correspondence Entered
Apr 16, 2020
Correspondence Received In Law Office
Apr 15, 2020
Assigned To Lie
Apr 8, 2020
Teas Response To Office Action Received
Oct 31, 2019
Notification Of Priority Action E-Mailed
Oct 31, 2019
Priority Action E-Mailed
Oct 31, 2019
Priority Action Written
Oct 16, 2019
Assigned To Examiner
Aug 27, 2019
Notice Of Design Search Code E-Mailed
Aug 24, 2019
New Application Office Supplied Data Entered
Aug 10, 2019
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24